[Training] CAJAL Advanced Neuroscience Training Programme

The CAJAL Advanced Neuroscience Training Programme represents commitment by the five partner institutions FENS, IBRO, the Gatsby Charitable Foundation, University of Bordeaux and the Champalimaud Foundation to establish a dedicated neuroscience training facility in Europe.

This European training programme provides two-or-three-week hands-on courses to a group of about 20 international advanced students (early career scientists: PhD students and early postdocs) in two major European neuroscience facilities. Courses are project-based and designed by first-class neuroscientists.


[Training] PhD programme in Translational Neuroscience in Edinburgh

Edinburgh Neuroscience hosts a Wellcome Trust funded 4 year PhD programme in Translational Neuroscience: Lifecourse influences on human brain health.

This prestigious, and innovative, research and 'Training to Translate'  programme will address a current global need by focussing on the advancement of knowledge, expertise and skills in clinical translation and will draw on unique Edinburgh research strengths in diseases across the life-course to achieve this goal.


[Training] Advanced Methods for Preclinical Alzheimer Research

The "Advanced Methods for Preclinical Alzheimer Research" workshop will take place Jan 21-Feb 2, 2019, in Bordeaux School of Neuroscience

The workshop is based on direct hands-on training on state-of-the-art methodology for Alzheimer disease research. It includes advanced cellular and brain imaging, electrophysiology, biochemical and behavioral methods. The workshop will cover a broad range of research models of Alzheimer disease, from IPS cells and drosophila, to mutant mice and human.

More information on
Deadline for application September 30th, 2018.
Stipends are available upon request.

[Job] PhD: study of the energetic metabolism in vivo by glucose CEST-MRI

August 29, 2018

PhD title: Methodological developments in metabolic imaging by CEST-MRI for the detection and quantification of glucose - applications to Alzheimer's disease

Glucose is the main source of energy production, particularly in the brain. Compelling evidence indicates a key role of glucose metabolism defects in several neurodegenerative diseases. A new magnetic resonance imaging modality (chemical exchange saturation transfer or CEST), has been proposed to image glucose non-invasively with high spatial and temporal resolutions. This magnetic resonance imaging (MRI) method called glucoCEST could offer a new tool to map energy metabolism in healthy and pathological mouse brain. However, this method is currently limited by the lack of specificity. Indeed, only relative changes in glucoCEST signal are reported but such measurements provide little information about absolute variations of glucose concentration and its degradation products through glycolytic pathway into the brain. In addition to the methodological aspect of the CEST acquisitions, the quantitative aspect is currently one of the major limitations of CEST imaging which prevents the transfer of the technique for clinical applications.
In this context, the goals of this project are first to push methodological developments of glucoCEST acquisition, then to develop innovative tools to quantify the glucoCEST signal in order to establish quantitative maps of glucose utilization in vivo using pharmacokinetics models, and finally, to demonstrate that our method may be a relevant biomarker of brain energy metabolism alterations in Alzheimer’s disease using a well characterized mouse model.


[Job] EATRIS seeks a business development manager

June 18, 2018

Workplace Coordination & Support Office of EATRIS ERIC at the VU University Medical Center
Date 18 June 2018
Location Amsterdam, The Netherlands
Hours 32-40 hours per week


The role: Performing business development for EATRIS, the permanent European infrastructure for translational medicine research

EATRIS is a European academic research infrastructure in translational medicine, established in 2014. The mission of EATRIS is to utilize cutting edge technologies and expertise to improve translation of scientific results into new therapies and diagnostics. We do this by identifying tools and technologies that can support drug and diagnostic development. One of our major strategies to fulfill our mission is to facilitate industry-academic collaborations using these facilities. Our 88 research institutions in 12 EU countries provide capacity and expertise to support research requests.

The Business Development Manager serves as a market connector within EATRIS, using a wide range of activities to scout external leads and obtain insightful market intelligence. From this intelligence, key internal and external contacts are developed toward enduring relationships. This network is continuously engaged to find potential matches between internal research interests and external commercial needs. This position requires broad insight about current and emerging activities in drug discovery, the current landscape in personalized medicine R&D, diagnostics and devices, as well as clinical development strategies. In addition to explicit knowledge about the life science industry, this position relies upon an individual who possesses an equal mixture of business intuition, strategic insights, curiosity about drug development, and an intense drive to develop new business.

Find out more here:

[Training] The "Brain to market" summer school at ICM

The "Brain to Market" summer school is novel and innovative program of training combine both translational neuroscience and entrepreunarial formation aim to change participants‘s mindset organized by the Brain and Spine Institute in Paris.

Targeting audience from various origins, the main aim of this summer school is to provide a high level training in a 360° environment, giving to participants a comprehensive overview of reality and issues of the economic and industrial sphere.

During a 5 days period, through an intensive training, participants are challenged on research issues, different each year, with a final aim to imagine together medicine for tomorrow.


[Training] Optical Imaging and Electrophysiological Recording in Neuroscience

An 11-day residential course of lectures, demonstrations and practical work (14–25 May 2018)


[Job] Post-Doc - Research Associate in cellular and molecular neurobiology - Brain and Spine Institute, Paris, France

15 janvier 2018

Research Associate in Cellular and Molecular Neurobiology - Brain and Spine Institute, Paris, France


The Brain and Spine Institute – ICM – is an international brain and spinal cord research center whose innovative concept and structure bring patients, doctors and researchers together with the aim of rapidly developing treatments for disorders of the nervous system and enable patients to benefit from them as quickly as possible.


[Training] ENLIGHT-TEN Translational Medicine Course 2018

Interested in discovering the landscape of Translational Medicine?
Want to learn about the job profiles of scientists in Industry?

Then join the 2018 course “Translational Research and Medicine Development” which will be hosted by Bayer in Berlin from 16.-20. April 2018 as part of the Marie Curie project ENLIGHT-TEN. The fee of 300 Euro includes the 5 day course in Berlin, catering during the course, two dinners and the e-learning.


[Job] Post-doctorate - Clinical Neuropsychologist at Mondor Institute of Biomedical Research, Créteil

June 14, 2017

Job title

Post-doctorate – Clinical Neuropsychologist




The Interventional Neuropsychology Team (NPI), a joint research unit (INSERM, UPEC, ENS), led by Prof. Anne-Catherine Bachoud-Lévi is recruiting a post-doctoral researcher in neuropsychology to develop cognitive tools for the follow-up of patients with neurodegenerative diseases.

The NPI team is present on two sites:

▪     The Mondor Institute of Biomedical Research in Créteil (

▪     l’Institut d’Etudes de la Cognition (  at Ecole normale supérieure in Paris.

The originality of the NPI team is based on the combination of fundamental research in cognition and clinical research in neuropsychology and biotherapies of neurodegenerative diseases.


Professor Anne-Catherine Bachoud-Lévi

Main task

The main objective of this project is to develop and validate new protocols for the evaluation of cognitive, psychiatric and motor impairments as well as functional abilities of patients with neurodegenerative diseases and in particular of Huntington's disease. This research project is part of the European Repair-HD program ( The protocols developed will have to be rapidly applied to cell and gene therapy clinical trials in Huntington patients and will eventually be extended to other pathologies.


▪     Doctorate in cognitive sciences / neuropsychology / neurosciences

▪     Knowledge in social cognition and/or language processing

▪     Training and experience in neuropsychology and cognition

▪     Ability to perform psychometric and cognitive tests with patients

▪     Proficiency in statistical analysis tools

▪     Fluent English and French (written and oral)

Documents to send

▪     CV

▪     Cover letter

▪     Reference letters


According to experience

Type of contract

Fixed-term contact (1 year renewable)

Start date

As soon as possible


This email address is being protected from spambots. You need JavaScript enabled to view it. et This email address is being protected from spambots. You need JavaScript enabled to view it.

[Job] Business Development Officer

7 juillet 2014
NeurATRIS recrute un Business Development Officer
Objectif : développer les partenariats industriels de NeurATRIS